Kraig Biocraft Laboratories (KBLB) Shares Outstanding (2011 - 2026)

Kraig Biocraft Laboratories has reported Shares Outstanding (Entity) for 16 years, with the latest figure at $1.1 billion in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 4.39% year-over-year to $1.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.1 billion (up 4.39% YoY) and the FY2025 annual result came in at $1.1 billion, up 4.39% from the prior year.
• Shares Outstanding (Entity) rose to $1.1 billion in Q4 2025 per KBLB's latest filing, from $1.1 billion in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $1.1 billion in Q4 2025 and troughed at $856.7 million in Q1 2021.
• A 5-year average of $1.0 billion and a median of $1.0 billion in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) gained 12.25% in 2022, then changed 0.0% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $927.4 million in 2021, then grew by 11.17% to $1.0 billion in 2022, then climbed by 0.72% to $1.0 billion in 2023, then changed by 0.0% to $1.0 billion in 2024, then increased by 4.39% to $1.1 billion in 2025.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.